# OnCo record paper-mahalingam-nat-med (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mahalingam-nat-med/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mahalingam-nat-med" ;
  schema:name "Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 41981308 and published in Nature Medicine; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-mahalingam-nat-med/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-026-04327-4>, <https://pubmed.ncbi.nlm.nih.gov/41981308/>, <https://europepmc.org/article/MED/41981308> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/s41591-026-04327-4> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Mahalingam D, Shroff RT, Carneiro BA, et al." ;
  onco:trials <https://onco.cc/trials/actuate-1801/> ;
  onco:journals <https://onco.cc/journals/nature-medicine/> .